Share Price and Basic Stock Data
Last Updated: February 25, 2025, 11:04 am
PEG Ratio | 2.05 |
---|
Competitors of NESCO Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
NESCO Ltd | 6,379 Cr. | 905 | 1,082/749 | 16.3 | 345 | 0.66 % | 22.4 % | 17.0 % | 2.00 |
DCM Shriram Ltd | 15,325 Cr. | 983 | 1,371/832 | 28.2 | 426 | 0.67 % | 8.99 % | 6.60 % | 2.00 |
Balmer Lawrie & Company Ltd | 2,868 Cr. | 168 | 320/152 | 11.1 | 104 | 5.07 % | 15.6 % | 14.7 % | 10.0 |
3M India Ltd | 30,181 Cr. | 26,780 | 41,000/26,222 | 49.4 | 1,906 | 0.60 % | 40.5 % | 30.5 % | 10.0 |
Industry Average | 13,688.25 Cr | 7,209.00 | 26.25 | 695.25 | 1.75% | 21.87% | 17.20% | 6.00 |
Quarterly Result
Metric | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 82 | 75 | 73 | 81 | 93 | 91 | 103 | 143 | 143 | 157 | 137 | 175 | 178 |
Expenses | 30 | 28 | 27 | 30 | 32 | 28 | 37 | 42 | 61 | 58 | 50 | 66 | 64 |
Operating Profit | 53 | 48 | 46 | 50 | 61 | 63 | 67 | 101 | 82 | 99 | 86 | 109 | 114 |
OPM % | 64% | 63% | 63% | 62% | 65% | 69% | 65% | 71% | 57% | 63% | 63% | 62% | 64% |
Other Income | 18 | 10 | 13 | 10 | 10 | 12 | 8 | 16 | 19 | 20 | 25 | 23 | 27 |
Interest | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 5 | 3 | 2 | 3 | 5 | 6 |
Depreciation | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 14 | 14 | 14 |
Profit before tax | 63 | 49 | 50 | 51 | 61 | 64 | 63 | 104 | 90 | 109 | 94 | 112 | 121 |
Tax % | 22% | 19% | 16% | 13% | 20% | 16% | 15% | 22% | 22% | 22% | 19% | 22% | 23% |
Net Profit | 49 | 40 | 42 | 44 | 49 | 54 | 54 | 82 | 70 | 85 | 76 | 88 | 94 |
EPS in Rs | 6.94 | 5.64 | 6.00 | 6.25 | 7.01 | 7.60 | 7.63 | 11.63 | 9.95 | 12.05 | 10.80 | 12.46 | 13.31 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 128 | 143 | 161 | 194 | 261 | 306 | 304 | 360 | 432 | 291 | 337 | 546 | 646 |
Expenses | 43 | 43 | 51 | 56 | 73 | 92 | 88 | 128 | 153 | 105 | 117 | 178 | 238 |
Operating Profit | 85 | 101 | 110 | 138 | 189 | 214 | 216 | 233 | 278 | 186 | 221 | 368 | 408 |
OPM % | 66% | 70% | 68% | 71% | 72% | 70% | 71% | 65% | 64% | 64% | 65% | 67% | 63% |
Other Income | 17 | 19 | 18 | 28 | 33 | 43 | 36 | 32 | 42 | 65 | 43 | 44 | 94 |
Interest | 1 | 1 | 0 | 0 | 4 | 5 | 6 | 5 | 6 | 8 | 9 | 12 | 15 |
Depreciation | 3 | 6 | 11 | 7 | 7 | 8 | 11 | 12 | 22 | 26 | 28 | 33 | 52 |
Profit before tax | 97 | 114 | 117 | 160 | 211 | 244 | 235 | 248 | 292 | 216 | 227 | 367 | 436 |
Tax % | 30% | 28% | 31% | 30% | 32% | 30% | 25% | 27% | 20% | 20% | 16% | 21% | |
Net Profit | 67 | 82 | 81 | 112 | 144 | 169 | 177 | 180 | 234 | 172 | 189 | 291 | 343 |
EPS in Rs | 9.55 | 11.59 | 11.49 | 15.83 | 20.45 | 24.03 | 25.08 | 25.57 | 33.18 | 24.48 | 26.85 | 41.25 | 48.62 |
Dividend Payout % | 6% | 6% | 9% | 8% | 8% | 9% | 9% | 10% | 9% | 12% | 11% | 11% |
YoY Net Profit Growth
Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 22.39% | -1.22% | 38.27% | 28.57% | 17.36% | 4.73% | 1.69% | 30.00% | -26.50% | 9.88% | 53.97% |
Change in YoY Net Profit Growth (%) | 0.00% | -23.61% | 39.49% | -9.70% | -11.21% | -12.63% | -3.04% | 28.31% | -56.50% | 36.38% | 44.08% |
NESCO Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 13% |
3 Years: | 33% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 15% |
3 Years: | 28% |
TTM: | 14% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 5% |
3 Years: | 18% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 15% |
3 Years: | 15% |
Last Year: | 17% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 7:59 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 352 | 425 | 526 | 667 | 837 | 995 | 1,154 | 1,341 | 1,512 | 1,681 | 1,950 | 2,282 | 2,417 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
Other Liabilities | 81 | 122 | 137 | 159 | 181 | 170 | 178 | 252 | 293 | 273 | 298 | 354 | 378 |
Total Liabilities | 447 | 561 | 676 | 840 | 1,032 | 1,179 | 1,346 | 1,607 | 1,819 | 1,969 | 2,263 | 2,650 | 2,810 |
Fixed Assets | 158 | 160 | 159 | 165 | 188 | 229 | 213 | 776 | 759 | 846 | 804 | 757 | 736 |
CWIP | 4 | 5 | 100 | 143 | 262 | 357 | 509 | 2 | 51 | 82 | 86 | 162 | 259 |
Investments | 258 | 368 | 384 | 442 | 482 | 499 | 531 | 672 | 810 | 847 | 1,161 | 1,494 | 1,594 |
Other Assets | 26 | 28 | 33 | 90 | 99 | 94 | 93 | 157 | 199 | 194 | 212 | 237 | 222 |
Total Assets | 447 | 561 | 676 | 840 | 1,032 | 1,179 | 1,346 | 1,607 | 1,819 | 1,969 | 2,263 | 2,650 | 2,810 |
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 85.00 | 101.00 | 110.00 | 138.00 | 189.00 | 214.00 | 216.00 | 233.00 | 278.00 | 186.00 | 220.00 | 368.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 25 | 25 | 20 | 20 | 13 | 16 | 18 | 14 | 37 | 20 | 15 | 7 |
Inventory Days | 158 | 184 | 313 | 139 | 158 | 107 | 119 | 83 | ||||
Days Payable | 253 | 312 | 519 | 166 | 227 | 125 | 147 | 93 | ||||
Cash Conversion Cycle | -70 | -102 | 20 | 20 | -193 | 16 | -8 | 14 | -32 | 2 | -12 | -4 |
Working Capital Days | -48 | -55 | -39 | -18 | -23 | -112 | -53 | -37 | -55 | 2 | 3 | -21 |
ROCE % | 35% | 25% | 29% | 35% | 32% | 26% | 23% | 24% | 16% | 15% | 22% | 22% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Franklin India Smaller Companies Fund | 1,229,164 | 0.89 | 105.68 | 4,350 | 2025-02-22 | 28156.64% |
UTI Small Cap Fund | 364,285 | 0.84 | 31.32 | 4,350 | 2025-02-22 | 8274.37% |
Bandhan Core Equity Fund | 185,099 | 0.43 | 15.91 | 4,350 | 2025-02-22 | 4155.15% |
WhiteOak Capital Flexi Cap Fund | 50,000 | 0.14 | 4.3 | 4,350 | 2025-02-22 | 1049.43% |
WhiteOak Capital Mid Cap Fund | 43,516 | 0.24 | 3.74 | 4,350 | 2025-02-22 | 900.37% |
WhiteOak Capital ELSS Tax Saver Fund | 4,350 | 0.26 | 0.37 | 4,350 | 2025-02-22 | 0% |
ICICI Prudential S&P BSE 500 ETF | 252 | 0.01 | 0.02 | 4,350 | 2025-02-22 | -94.21% |
Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 41.25 | 26.85 | 24.48 | 33.19 | 25.61 |
Diluted EPS (Rs.) | 41.25 | 26.85 | 24.48 | 33.19 | 25.61 |
Cash EPS (Rs.) | 45.90 | 30.87 | 28.13 | 36.38 | 27.29 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 278.82 | 240.95 | 217.04 | 192.66 | 166.12 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 278.82 | 240.95 | 217.04 | 192.66 | 166.12 |
Revenue From Operations / Share (Rs.) | 77.49 | 47.88 | 41.31 | 61.27 | 51.23 |
PBDIT / Share (Rs.) | 58.47 | 37.47 | 35.52 | 45.52 | 37.54 |
PBIT / Share (Rs.) | 53.81 | 33.45 | 31.87 | 42.34 | 35.85 |
PBT / Share (Rs.) | 52.08 | 32.14 | 30.70 | 41.48 | 35.18 |
Net Profit / Share (Rs.) | 41.25 | 26.85 | 24.48 | 33.19 | 25.61 |
NP After MI And SOA / Share (Rs.) | 41.25 | 26.85 | 24.48 | 33.19 | 25.61 |
PBDIT Margin (%) | 75.45 | 78.24 | 85.96 | 74.29 | 73.27 |
PBIT Margin (%) | 69.44 | 69.85 | 77.13 | 69.09 | 69.98 |
PBT Margin (%) | 67.21 | 67.11 | 74.30 | 67.70 | 68.68 |
Net Profit Margin (%) | 53.22 | 56.06 | 59.24 | 54.17 | 49.98 |
NP After MI And SOA Margin (%) | 53.22 | 56.06 | 59.24 | 54.17 | 49.98 |
Return on Networth / Equity (%) | 14.79 | 11.14 | 11.27 | 17.22 | 15.41 |
Return on Capital Employeed (%) | 17.63 | 12.43 | 13.21 | 19.77 | 20.07 |
Return On Assets (%) | 12.84 | 9.59 | 9.46 | 14.52 | 13.37 |
Asset Turnover Ratio (%) | 0.25 | 0.17 | 0.16 | 0.29 | 0.28 |
Current Ratio (X) | 4.70 | 3.73 | 1.73 | 1.10 | 0.77 |
Quick Ratio (X) | 4.59 | 3.63 | 1.67 | 1.01 | 0.67 |
Inventory Turnover Ratio (X) | 3.89 | 3.40 | 1.95 | 2.00 | 2.10 |
Dividend Payout Ratio (NP) (%) | 7.27 | 11.17 | 0.00 | 16.56 | 8.98 |
Dividend Payout Ratio (CP) (%) | 6.53 | 9.71 | 0.00 | 15.11 | 8.42 |
Earning Retention Ratio (%) | 92.73 | 88.83 | 0.00 | 83.44 | 91.02 |
Cash Earning Retention Ratio (%) | 93.47 | 90.29 | 0.00 | 84.89 | 91.58 |
Interest Coverage Ratio (X) | 33.74 | 28.63 | 30.45 | 53.24 | 56.11 |
Interest Coverage Ratio (Post Tax) (X) | 24.80 | 21.52 | 21.98 | 39.83 | 39.27 |
Enterprise Value (Cr.) | 3626.03 | 3885.86 | 3706.85 | 3428.55 | 3388.83 |
EV / Net Operating Revenue (X) | 6.64 | 11.52 | 12.73 | 7.94 | 9.39 |
EV / EBITDA (X) | 8.80 | 14.72 | 14.81 | 10.69 | 12.81 |
MarketCap / Net Operating Revenue (X) | 6.67 | 11.55 | 12.77 | 7.97 | 9.41 |
Retention Ratios (%) | 92.72 | 88.82 | 0.00 | 83.43 | 91.01 |
Price / BV (X) | 1.85 | 2.29 | 2.43 | 2.54 | 2.90 |
Price / Net Operating Revenue (X) | 6.67 | 11.55 | 12.77 | 7.97 | 9.41 |
EarningsYield | 0.07 | 0.04 | 0.04 | 0.06 | 0.05 |
After reviewing the key financial ratios for NESCO Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
- For Diluted EPS (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
- For Cash EPS (Rs.), as of Mar 23, the value is 45.90. This value is within the healthy range. It has increased from 30.87 (Mar 22) to 45.90, marking an increase of 15.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 278.82. It has increased from 240.95 (Mar 22) to 278.82, marking an increase of 37.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 278.82. It has increased from 240.95 (Mar 22) to 278.82, marking an increase of 37.87.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 77.49. It has increased from 47.88 (Mar 22) to 77.49, marking an increase of 29.61.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 58.47. This value is within the healthy range. It has increased from 37.47 (Mar 22) to 58.47, marking an increase of 21.00.
- For PBIT / Share (Rs.), as of Mar 23, the value is 53.81. This value is within the healthy range. It has increased from 33.45 (Mar 22) to 53.81, marking an increase of 20.36.
- For PBT / Share (Rs.), as of Mar 23, the value is 52.08. This value is within the healthy range. It has increased from 32.14 (Mar 22) to 52.08, marking an increase of 19.94.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
- For PBDIT Margin (%), as of Mar 23, the value is 75.45. This value is within the healthy range. It has decreased from 78.24 (Mar 22) to 75.45, marking a decrease of 2.79.
- For PBIT Margin (%), as of Mar 23, the value is 69.44. This value exceeds the healthy maximum of 20. It has decreased from 69.85 (Mar 22) to 69.44, marking a decrease of 0.41.
- For PBT Margin (%), as of Mar 23, the value is 67.21. This value is within the healthy range. It has increased from 67.11 (Mar 22) to 67.21, marking an increase of 0.10.
- For Net Profit Margin (%), as of Mar 23, the value is 53.22. This value exceeds the healthy maximum of 10. It has decreased from 56.06 (Mar 22) to 53.22, marking a decrease of 2.84.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 53.22. This value exceeds the healthy maximum of 20. It has decreased from 56.06 (Mar 22) to 53.22, marking a decrease of 2.84.
- For Return on Networth / Equity (%), as of Mar 23, the value is 14.79. This value is below the healthy minimum of 15. It has increased from 11.14 (Mar 22) to 14.79, marking an increase of 3.65.
- For Return on Capital Employeed (%), as of Mar 23, the value is 17.63. This value is within the healthy range. It has increased from 12.43 (Mar 22) to 17.63, marking an increase of 5.20.
- For Return On Assets (%), as of Mar 23, the value is 12.84. This value is within the healthy range. It has increased from 9.59 (Mar 22) to 12.84, marking an increase of 3.25.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.25. It has increased from 0.17 (Mar 22) to 0.25, marking an increase of 0.08.
- For Current Ratio (X), as of Mar 23, the value is 4.70. This value exceeds the healthy maximum of 3. It has increased from 3.73 (Mar 22) to 4.70, marking an increase of 0.97.
- For Quick Ratio (X), as of Mar 23, the value is 4.59. This value exceeds the healthy maximum of 2. It has increased from 3.63 (Mar 22) to 4.59, marking an increase of 0.96.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.89. This value is below the healthy minimum of 4. It has increased from 3.40 (Mar 22) to 3.89, marking an increase of 0.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 7.27. This value is below the healthy minimum of 20. It has decreased from 11.17 (Mar 22) to 7.27, marking a decrease of 3.90.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 6.53. This value is below the healthy minimum of 20. It has decreased from 9.71 (Mar 22) to 6.53, marking a decrease of 3.18.
- For Earning Retention Ratio (%), as of Mar 23, the value is 92.73. This value exceeds the healthy maximum of 70. It has increased from 88.83 (Mar 22) to 92.73, marking an increase of 3.90.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 93.47. This value exceeds the healthy maximum of 70. It has increased from 90.29 (Mar 22) to 93.47, marking an increase of 3.18.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 33.74. This value is within the healthy range. It has increased from 28.63 (Mar 22) to 33.74, marking an increase of 5.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 24.80. This value is within the healthy range. It has increased from 21.52 (Mar 22) to 24.80, marking an increase of 3.28.
- For Enterprise Value (Cr.), as of Mar 23, the value is 3,626.03. It has decreased from 3,885.86 (Mar 22) to 3,626.03, marking a decrease of 259.83.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 11.52 (Mar 22) to 6.64, marking a decrease of 4.88.
- For EV / EBITDA (X), as of Mar 23, the value is 8.80. This value is within the healthy range. It has decreased from 14.72 (Mar 22) to 8.80, marking a decrease of 5.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 6.67. This value exceeds the healthy maximum of 3. It has decreased from 11.55 (Mar 22) to 6.67, marking a decrease of 4.88.
- For Retention Ratios (%), as of Mar 23, the value is 92.72. This value exceeds the healthy maximum of 70. It has increased from 88.82 (Mar 22) to 92.72, marking an increase of 3.90.
- For Price / BV (X), as of Mar 23, the value is 1.85. This value is within the healthy range. It has decreased from 2.29 (Mar 22) to 1.85, marking a decrease of 0.44.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 6.67. This value exceeds the healthy maximum of 3. It has decreased from 11.55 (Mar 22) to 6.67, marking a decrease of 4.88.
- For EarningsYield, as of Mar 23, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 22) to 0.07, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in NESCO Ltd:
- Net Profit Margin: 53.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.63% (Industry Average ROCE: 21.87%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.79% (Industry Average ROE: 17.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 24.8
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.3 (Industry average Stock P/E: 26.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 53.22%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Diversified | Nesco Center, Western Express Highway, Mumbai Maharashtra 400063 | companysecretary@nesco.in http://www.nesco.in |
Management | |
---|---|
Name | Position Held |
Mr. Krishna S Patel | Chairman & Managing Director |
Mrs. Sudha S Patel | Non Exe.Non Ind.Director |
Ms. Amrita V Chowdhury | Independent Director |
Mr. Mahendra K Chouhan | Independent Director |
Dr. Ramakrishnan Ramamurthi | Independent Director |
Mr. Manish I Panchal | Independent Director |
Mr. Arun L Todarwal | Independent Director |
FAQ
What is the latest intrinsic value of NESCO Ltd?
Let's break down NESCO Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 25 February 2025:
- Calculated Fair Value: ₹769.84
- Current Market Price: ₹905.00
- Variance: 14.93% lower
This suggests NESCO Ltd is currently overvalued by 14.93%. For context:
- Market Cap: 6,379 Cr.
- 52-Week Range: 1,082/749
- Reserves (Sep 2024): ₹2,417 Cr
- Liabilities: 2,810 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of NESCO Ltd?
The Market Cap of NESCO Ltd is 6,379 Cr..
What is the current Stock Price of NESCO Ltd as on 25 February 2025?
The current stock price of NESCO Ltd as on 25 February 2025 is ₹905.
What is the High / Low of NESCO Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of NESCO Ltd stocks is 1,082/749.
What is the Stock P/E of NESCO Ltd?
The Stock P/E of NESCO Ltd is 16.3.
What is the Book Value of NESCO Ltd?
The Book Value of NESCO Ltd is 345.
What is the Dividend Yield of NESCO Ltd?
The Dividend Yield of NESCO Ltd is 0.66 %.
What is the ROCE of NESCO Ltd?
The ROCE of NESCO Ltd is 22.4 %.
What is the ROE of NESCO Ltd?
The ROE of NESCO Ltd is 17.0 %.
What is the Face Value of NESCO Ltd?
The Face Value of NESCO Ltd is 2.00.